Marbofloxacin

Sort by

Marbofloxacin EP Impurity A

  • CAT NUMBER DCTI-C-2330
  • CAS NUMBER 115551-40-1
  • MOLECULAR FORMULA C11H8F2N2O4
  • MOLECULAR WEIGHT 270.19

Marbofloxacin EP Impurity B

  • CAT NUMBER DCTI-C-2331
  • CAS NUMBER 115551-41-2
  • MOLECULAR FORMULA C12H8F2N2O4
  • MOLECULAR WEIGHT 282.2

Marbofloxacin EP Impurity D

  • CAT NUMBER DCTI-C-2332
  • CAS NUMBER 117380-92-4
  • MOLECULAR FORMULA C16H19FN4O4
  • MOLECULAR WEIGHT 350.35

Marbofloxacin Impurity C

  • CAT NUMBER DCTI-C-2334
  • CAS NUMBER 100276-37-7
  • MOLECULAR FORMULA C16H18F2N4O3
  • MOLECULAR WEIGHT 352.34

Marbofloxacin Impurity E

  • CAT NUMBER DCTI-C-2333
  • CAS NUMBER 2249835-04-7
  • MOLECULAR FORMULA C18H23FN4O4
  • MOLECULAR WEIGHT 378.4

General Information

Marbofloxacin Impurities and Marbofloxacin

For evaluating the purity and safety of Marbofloxacin, an active pharmaceutical ingredient, Daicel Pharma offers a customized synthesis of Marbofloxacin impurity standards. These impurity standards include crucial compounds such as Marbofloxacin EP Impurity A, Marbofloxacin EP Impurity B, Marbofloxacin EP Impurity D, Marbofloxacin Impurity C, and Marbofloxacin Impurity E. Additionally, Daicel Pharma provides worldwide delivery options for Marbofloxacin impurity standards.

Marbofloxacin [CAS: 115550-35-1] is a carboxylic acid compound classified as a third-generation fluoroquinolone antibiotic. It is used in veterinary medicine. It has antimicrobial activity and treats dermatological, respiratory, and urinary tract infections from Gram-positive and Gram-negative bacteria.

Marbofloxacin: Use and Commercial Availability 

Marbofloxacin, marketed as Marbocyl, Zeniquin, etc., is a newer fluoroquinolone antibiotic known for its broad spectrum of activity against various bacteria and mycoplasmas. It exhibits bactericidal properties. Marbofloxacin treats bone infections, urinary tract infections, skin infections, and infections caused by intracellular organisms.

Marbofloxacin Structure and Mechanism of ActionMarbofloxacin Structure and Mechanism of Action

The chemical name of Marbofloxacin is 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid. Its chemical formula is C17H19FN4O4, and its molecular weight is approximately 362.4 g/mol.

Marbofloxacin inhibits DNA gyrase and topoisomerase IV, enzymes crucial for DNA replication and repairs.

Marbofloxacin Impurities and Synthesis

Regular testing and monitoring of Marbofloxacin impurities are essential to maintain the drug’s purity and integrity. Marbofloxacin, a fluoroquinolone antibiotic, may contain impurities originating from manufacturing1 or degradation. They can include related substances, degradation products, or residual solvents used during production. Strict adherence to regulatory standards ensures permissible impurity levels in Marbofloxacin formulations, guaranteeing product safety and efficacy. Rigorous quality control measures and analytical techniques help identify and quantify impurities in Marbofloxacin samples. This monitoring ensures that Marbofloxacin maintains its effectiveness and quality throughout its shelf life.

Daicel Pharma strictly adheres to cGMP standards and operates an analytical facility for the preparation of Marbofloxacin impurity standards, which include Marbofloxacin EP Impurity A, Marbofloxacin EP Impurity B, Marbofloxacin EP Impurity D, Marbofloxacin Impurity C, and Marbofloxacin Impurity E. Our Marbofloxacin impurity standards have a detailed Certificate of Analysis (CoA) that provides a comprehensive characterization report. This report includes data obtained through techniques, 1H NMR, 13C NMR, IR, MASS, and HPLC purity analysis2. Upon request, we give additional data like 13C-DEPT. Moreover, we can synthesize unknown Marbofloxacin impurity standards and degradation products. Each delivery has a comprehensive characterization report.

References
FAQ's

Frequently Asked Questions

Some impurities in Marbofloxacin can contribute to degradation, affecting the drug's stability and shelf life. Proper storage conditions maintain product quality.

Marbofloxacin impurities within acceptable limits may not affect its therapeutic efficacy. The active ingredient is primarily responsible for the drug's therapeutic effects.

Impurities in Marbofloxacin can potentially undergo chemical reactions within the body, but their occurrence and impact depend on their specificity and reactivity.

Marbofloxacin impurities should be stored, at a controlled room temperature, usually between 2-8 °C.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart